JP2009512699A - 遅延放出とその後の持続放出の腸溶性を有する液体剤形 - Google Patents

遅延放出とその後の持続放出の腸溶性を有する液体剤形 Download PDF

Info

Publication number
JP2009512699A
JP2009512699A JP2008536688A JP2008536688A JP2009512699A JP 2009512699 A JP2009512699 A JP 2009512699A JP 2008536688 A JP2008536688 A JP 2008536688A JP 2008536688 A JP2008536688 A JP 2008536688A JP 2009512699 A JP2009512699 A JP 2009512699A
Authority
JP
Japan
Prior art keywords
dosage form
concentration
active substance
oral dosage
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008536688A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009512699A5 (enExample
Inventor
ユアン，ジンファ
ミード クリプス，ナンシー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastman Chemical Co
Original Assignee
Eastman Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastman Chemical Co filed Critical Eastman Chemical Co
Publication of JP2009512699A publication Critical patent/JP2009512699A/ja
Publication of JP2009512699A5 publication Critical patent/JP2009512699A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2008536688A 2005-10-24 2006-10-11 遅延放出とその後の持続放出の腸溶性を有する液体剤形 Pending JP2009512699A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/257,432 US20070092559A1 (en) 2005-10-24 2005-10-24 Liquid dosage forms having enteric properties of delayed and then sustained release
PCT/US2006/039761 WO2007050294A2 (en) 2005-10-24 2006-10-11 Liquid dosage forms having enteric properties of delayed and then sustained release

Publications (2)

Publication Number Publication Date
JP2009512699A true JP2009512699A (ja) 2009-03-26
JP2009512699A5 JP2009512699A5 (enExample) 2009-11-26

Family

ID=37744211

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008536688A Pending JP2009512699A (ja) 2005-10-24 2006-10-11 遅延放出とその後の持続放出の腸溶性を有する液体剤形

Country Status (5)

Country Link
US (1) US20070092559A1 (enExample)
EP (1) EP1940365A2 (enExample)
JP (1) JP2009512699A (enExample)
CN (1) CN101296690A (enExample)
WO (1) WO2007050294A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
ES2396051T3 (es) * 2006-04-26 2013-02-18 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal
WO2010044842A1 (en) * 2008-10-16 2010-04-22 University Of Tennessee Research Foundation Tamper resistant oral dosage forms containing an embolizing agent
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
GB2477590A (en) * 2010-02-05 2011-08-10 Biocopea Ltd A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US8895537B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating cardiovascular diseases
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
WO2016020901A1 (en) 2014-08-07 2016-02-11 Acerta Pharma B.V. Methods of treating cancers, immune and autoimmune diseases, and inflammatory diseases based on btk occupancy and btk resynthesis rate
CN110314152B (zh) * 2018-11-27 2021-03-26 西安圣雪沙药物开发有限公司 一种布洛芬缓释微丸胶囊及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242547A (en) * 1967-10-07 1971-08-11 Scherer Gmbh R P Depot medicaments in capsule form
JPS6322032A (ja) * 1986-05-01 1988-01-29 フア−マカツプス，インコ−ポレイテイド ゼラチン封入徐放性組成物及びその製造方法
US4727109A (en) * 1985-01-04 1988-02-23 R. P. Scherer Corporation Pharmaceutical preparation with an active substance of low solubility in water and gastric juices
JPS649932A (en) * 1987-07-01 1989-01-13 Toyo Capsel Kk Soft capsule preparation using newly combined component as the base

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1322306A (en) * 1971-04-15 1973-07-04 Meiji Seika Co Stabilized antibiotic preparation and manufacturing process therefor
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4835186A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JPH082781B2 (ja) * 1988-10-18 1996-01-17 嘉明 川島 中空顆粒状医薬及びその製法
US5527545A (en) * 1989-09-18 1996-06-18 Recordati S.A. Chemical And Pharmaceutical Company Liquid-suspension controlled-release pharmaceutical composition
IT1250654B (it) * 1991-07-08 1995-04-21 Farcon Ag Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
US5723151A (en) * 1995-11-06 1998-03-03 Eastman Chemical Company Cellulose acetate phthalate enteric coating compositions
DK0869810T3 (da) * 1996-06-19 2005-02-07 Novartis Ag Cyclosporinholdige blöde kapselpræparater
ES2234139T3 (es) * 1997-08-11 2005-06-16 Alza Corporation Forma de dosificacion de un agente activo de liberacion prolongada adaptada para la retencion gastrica.
US6191162B1 (en) * 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
US6312713B1 (en) * 1998-06-12 2001-11-06 Bernard Korol Polymer matrices for storage and sustained release of drugs and chemicals
US6139875A (en) * 1998-09-29 2000-10-31 Eastman Chemical Company Aqueous enteric coating composition and low gastric permeability enteric coating
US6174873B1 (en) * 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs
DE69915346T2 (de) * 1998-12-17 2004-07-22 Alza Corp., Mountain View Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
US6797283B1 (en) * 1998-12-23 2004-09-28 Alza Corporation Gastric retention dosage form having multiple layers
US6342249B1 (en) * 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
US6635281B2 (en) * 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
JP4610687B2 (ja) * 1999-11-15 2011-01-12 コニカミノルタホールディングス株式会社 原稿読み取り装置
US20040028744A1 (en) * 2002-06-17 2004-02-12 Sauwaluxana Tongaree Mucoadhesive composition
JP2007505129A (ja) * 2003-09-11 2007-03-08 グリュコン テクノロジーズ グループ エルエルシー （−）−ヒドロキシクエン酸の腸溶性送達物
GB0403808D0 (en) * 2004-02-20 2004-03-24 Bioprogress Technology Ltd Films for use as dosage forms

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242547A (en) * 1967-10-07 1971-08-11 Scherer Gmbh R P Depot medicaments in capsule form
US4727109A (en) * 1985-01-04 1988-02-23 R. P. Scherer Corporation Pharmaceutical preparation with an active substance of low solubility in water and gastric juices
JPS6322032A (ja) * 1986-05-01 1988-01-29 フア−マカツプス，インコ−ポレイテイド ゼラチン封入徐放性組成物及びその製造方法
JPS649932A (en) * 1987-07-01 1989-01-13 Toyo Capsel Kk Soft capsule preparation using newly combined component as the base

Also Published As

Publication number Publication date
EP1940365A2 (en) 2008-07-09
CN101296690A (zh) 2008-10-29
WO2007050294A3 (en) 2007-07-12
US20070092559A1 (en) 2007-04-26
WO2007050294A2 (en) 2007-05-03

Similar Documents

Publication Publication Date Title
US20070092559A1 (en) Liquid dosage forms having enteric properties of delayed and then sustained release
ES2582942T3 (es) Composiciones farmacéuticas de liberación controlada que comprenden un éster de ácido fumárico
US12214084B2 (en) Enteric hard capsule
US8940328B2 (en) Pellet formulation for the treatment of the intestinal tract
US5433951A (en) Sustained release formulation containing captopril and method
JP6007176B2 (ja) 保存に安定な製剤を製造するための結合剤の使用
KR102636273B1 (ko) 플로로글루시놀 및 트리메틸플로로글루시놀의 제약 제제
JP2017160241A (ja) 「経口医薬組成物」
BRPI0614417A2 (pt) composições farmacêuticas compreendendo bloqueadores de canais de cálcio de dihidropiridina e ácidos graxos de Èmega-3 e métodos de tratamento utilizando as mesmas
BR112015020453B1 (pt) Formas de dosagem de liberação prolongada orais de tofacitinibe e uso de tofacitinibe
SK36393A3 (en) Biphasic relase formulations for lipophilic drugs and method
KR20010041696A (ko) 발포성 장용(腸溶) 제제
TW202114701A (zh) 一種含有醋酸阿比特龍的藥物組合物及其製備方法和應用
JPH11505253A (ja) 結腸デリバリー用の医薬投与形態
AU2017204505A1 (en) Controlled release enteric soft capsules of fumarate esters
JP2009512699A5 (enExample)
DE69816624T2 (de) Verabreichungsform für sertralin mit verzögerter wirkstofffreigabe
JPH0451528B2 (enExample)
JP2003503444A (ja) ラテックス被膜を有する徐放性剤形単位及びその製造方法
WO2005053659A1 (en) An improved pharmaceutical formulation containing tamsulosin salt and a process for its preparation
KR101884230B1 (ko) 에소메프라졸을 포함하는 제제
CN1261794A (zh) 增溶的舍曲林组合物
JP2008539231A (ja) 濡れ性の向上した、医薬として許容され得る可塑剤が組み込まれたセルロース系フィルム
US20160000734A1 (en) Method and compositions of civamide to treat disease of the intestines
KR101096429B1 (ko) 안정성이 향상된 아세클로페낙의 경구용 연질캅셀제

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091008

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091008

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120517

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120605

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120904

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120911

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121030

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121211

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130521